Aevolve is a platform that supports global medical, biotech and and life science innovation from the research and development stage to full-scale commercialization. Utilizing blockchain technology, their innovation network called BioSpheres seamlessly connects patients, investors and innovators around the world to help increase efficacy, coordination and cooperation. This is possible through BioSpheres’ underlying asset, the AVEX token. Together, AEVOLVE, the Biospheres’ Platform and the AVEX token facilitate the development and commercialization of treatments and technologies that would otherwise not reach market availability.

Business Pioneer Rogelio (“Vonz”) Santos,Jr. as CEO of AEVOLVE in Monaco, has been pleased  with the warm reception his new vision-to provide an alternative source of funding for promising medical research projects, while serving millions of people worldwide who currently lack the treatment  they need – has received.

Mark Chester, as AEVOLVE’S COO, Bridges Technology & Humanity, joined Mark Santos in Monaco to lead a panel discussion on blockchain and medical Innovation. He believes that AEVOLVE offers the best solution for bridging the gaps between the medical innovators of the world and the millions of people who want access to the cures, treatments and life-extending technologies that they are developing.

Photos L. Mattera